Antiepileptic drugs and intrauterine death

Neurology

Volumn 85, Issue 7, 2015, Pages 580-588

  Tomson, Torbjörn ^a   Battino, Dina ^b   Bonizzoni, Erminio ^c   Craig, John J ^d   Lindhout, Dick ^e,f   Perucca, Emilio ^g   Sabers, Anne ^h   Thomas, Sanjeev V ⁱ   Vajda, Frank ^j  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^g UNIVERSITY OF PAVIA   (Italy)

^h Rigshospitalet   (Denmark)

ⁱ SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^j UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FOLIC ACID; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; COHORT ANALYSIS; CONCEPTION; CONGENITAL MALFORMATION; EDUCATIONAL STATUS; ENVIRONMENTAL EXPOSURE; EPILEPSY; FAMILY HISTORY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; GENERALIZED EPILEPSY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MONOTHERAPY; PERINATAL MORTALITY; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPONTANEOUS ABORTION; STILLBIRTH; THERAPY; ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ADVERSE EFFECTS; CHEMICALLY INDUCED; CONGENITAL ABNORMALITIES; DRUG COMBINATION; MIDDLE AGED; PREGNANCY COMPLICATIONS; REGISTER; RISK FACTOR; YOUNG ADULT;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ANTICONVULSANTS; CONGENITAL ABNORMALITIES; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; STILLBIRTH; YOUNG ADULT;

EID: 84939545012     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001840     Document Type: Article

References (20)

1. Meadow SR. Anticonvulsant drugs and congenital abnormalities. Lancet 1968;2:1296
2. Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 2009;73:133-141
3. Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012;11:803-813
4. Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD Study): a prospective observational study. Lancet Neurol 2013;12:244-252
5. Christensen J, Grønborg TK, Sørensen MJ, et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013;309:1696-1703
6. Tomson T, Battino D, Craig J, et al. Pregnancy registries: differences, similarities, and possible harmonization. Epilepsia 2010;51:909-915
7. Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP Epilepsy and Pregnancy Registry. Lancet Neurol 2011;10:609-617
8. Hernández-Díaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-1699
9. Campbell E, Kennedy F, Russell A, et al.Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry 2014;85:1029-1034
10. Bech BH, Kjaersgaard MI, Pedersen HS, et al. Use of antiepileptic drugs during pregnancy and risk of spontaneous abortion and stillbirth: population based cohort study. BMJ 2014;349:g5159
11. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399
12. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology. Epilepsia 2010;51:676-685
13. McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003;157:940-943
14. McLachlan GJ, Krishnan T. The EM Algorithm and Extensions. New York: John Wiley &Sons; 1997
15. Annegers JF, Baumgartner KB, Hauser WA, Kurland LT. Epilepsy, antiepileptic drugs, and the risk of spontaneous abortion. Epilepsia 1988;29:451-458
16. Flenady V, Middleton P, Smith GC, et al. Stillbirths: the way forward in high-income countries. Lancet 2011;377: 1703-1717
17. Garcia-Enguidanos A, Calle ME, Valero J, Luna S, Dominguez-Rojas V. Risk factors in miscarriage: a review. Eur J Obstet Gynecol Reprod Biol 2002;102:111-119
18. Schupf N, Ottman R. Reproduction among individuals with idiopathic/cryptogenic epilepsy: risk factors for spontaneous abortion. Epilepsia 1997;38:824-829
19. Pittschieler S, Brezinka C, Jahn B, et al. Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol 2008;255:1926-1931
20. Morrow JI, Hunt SJ, Russell AJ, et al. Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2009;80:506-511